These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6197723)

  • 1. Intact neurotensin (NT) in human plasma: response to oral feeding.
    Shaw C; Buchanan KD
    Regul Pept; 1983 Oct; 7(2):145-53. PubMed ID: 6197723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin-like immunoreactivities in human plasma: feeding responses and metabolism.
    Holst Pedersen J; Fahrenkrug J
    Peptides; 1986; 7(1):15-20. PubMed ID: 3714532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meal-stimulated neurotensin immunoreactivity in plasma following gastric surgery: characterisation with two region-specific antisera.
    Shaw C; Watt PC; Buchanan KD
    Digestion; 1986; 33(3):152-60. PubMed ID: 2419192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral fat on plasma levels of neurotensin and neurotensin fragments in humans. Characterization by high-pressure liquid chromatography.
    Draviam EJ; Upp JR; Greeley GH; Townsend CM; Thompson JC
    Dig Dis Sci; 1990 Feb; 35(2):200-4. PubMed ID: 2302977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human plasma neurotensin-like immunoreactivity after fat ingestion.
    Theodorsson-Norheim E; Rosell S
    Regul Pept; 1983 Jul; 6(3):207-18. PubMed ID: 6622752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of neurotensin and pancreatic polypeptide in man: role of the kidney and plasma factors.
    Shulkes A; Bijaphala S; Dawborn JK; Fletcher DR; Hardy KJ
    J Clin Endocrinol Metab; 1984 May; 58(5):873-9. PubMed ID: 6707191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of plasma neurotensinlike immunoreactivity after a meal. Characterization of the elevated components.
    Hammer RA; Carraway RE; Leeman SE
    J Clin Invest; 1982 Jul; 70(1):74-81. PubMed ID: 7085889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotensin in plasma: immunochemical and chromatographic character of acid/acetone-soluble material.
    Carraway R; Hammer RA; Leeman SE
    Endocrinology; 1980 Aug; 107(2):400-6. PubMed ID: 7389661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprandial release of neurotensin-like immunoreactivity and its mechanism.
    Matsumura M; Ohno M; Ohura M; Shimizu I; Kishi S; Saito S
    Gastroenterol Jpn; 1984 Dec; 19(6):543-9. PubMed ID: 6526253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma neurotensin in the conscious pig: release by individual food components and effects on exocrine pancreas secretion.
    Cuber JC; Philippe C; Abello J; Corring T; Levenez F; Chayvialle JA
    Pancreas; 1990 May; 5(3):306-13. PubMed ID: 2343043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ingestion of amino acids, glucose and fat on circulating neurotensin-like immunoreactivity (NTLI) in man.
    Rosell S; Rökaeus A
    Acta Physiol Scand; 1979 Nov; 107(3):263-67. PubMed ID: 539456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The stability and metabolism of intravenously administered neurotensin in the rat.
    Aronin N; Carraway RE; Ferris CF; Hammer RA; Leeman SE
    Peptides; 1982; 3(4):637-42. PubMed ID: 7134032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of nephrectomy and ureter ligation on plasma neurotensin-like immunoreactivity levels in the conscious rat.
    Theodorsson-Norheim E; Al-Saffar A; Saria A; Rosell S
    Acta Physiol Scand; 1985 Mar; 123(3):269-72. PubMed ID: 4061110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation and characterization of human plasma neurotensin-like immunoreactivity in response to a meal.
    Lee YC; Allen JM; Uttenthal LO; Roberts PM; Gill SS; Bloom SR
    Dig Dis Sci; 1985 Feb; 30(2):129-33. PubMed ID: 3838153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol and fatty acid stimulation of neurotensin release from rat small intestine.
    Ferris CF; Armstrong MJ; George JK; Stevens CA; Carraway RE; Leeman SE
    Endocrinology; 1985 Mar; 116(3):1133-8. PubMed ID: 3971900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ and plasma metabolism of neurotensin in sheep.
    Shulkes A; Fletcher DR; Hardy KJ
    Am J Physiol; 1983 Nov; 245(5 Pt 1):E457-62. PubMed ID: 6638173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic inhibition of meal stimulated plasma neurotensin like immunoreactivity in man.
    Fletcher DR; Shulkes A; Bladin PH; Booth D; Hardy KJ
    Life Sci; 1983 Aug; 33(9):863-9. PubMed ID: 6888194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolism of intravenously infused neurotensin in man and its chromatographic characterization in human plasma.
    Lee YC; Allen JM; Uttenthal LO; Walker MC; Shemilt J; Gill SS; Bloom SR
    J Clin Endocrinol Metab; 1984 Jul; 59(1):45-50. PubMed ID: 6725524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A radioimmunoassay for neurotensin in human plasma.
    Blackburn AM; Bloom SR
    J Endocrinol; 1979 Nov; 83(2):175-81. PubMed ID: 574894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between lower esophageal sphincter (LES) pressure and the plasma concentration of neurotensin during intravenous infusion of neurotensin(1-13) and (Gln4)neurotensin(1-13) in man.
    Theodorsson-Norheim E; Thor K; Rosell S
    Acta Physiol Scand Suppl; 1983; 515():29-35. PubMed ID: 6578671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.